Purchase Order 75D30124P18469
- Not listed
- This is a $350,484.00 firm fixed price purchase order awarded to Sony Biotechnology Inc. by the Centers for Disease Control and Prevention (CDC) for the delivery and installation of a SONY MA900 cell sorter. The contract has a period of performance ending on February 16, 2025. Sony Biotechnology Inc. is a specialized manufacturer of flow cytometry and imaging equipment, reagents, and maintenance services that has provided similar products and services to various federal agencies, including the...
- This is a definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Sony Biotechnology Inc. for the procurement of a SONY SH800 CELL SORTER. The contract has a ceiling value of $325,584.40 and an ultimate completion date of December 23, 2016. The contract does not utilize a set-aside designation. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to support...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), to Sony Biotechnology Inc. for maintenance of Sony laboratory equipment. The contract has a ceiling value of $106,200.00 and a period of performance from January 21, 2019 through January 20, 2024. The award was made on a sole-source basis, as Sony Biotechnology is the only provider capable of...
- Sony Biotechnology Inc., doing business as Sony Corp of America, was awarded a firm fixed-price purchase order valued at $290,578.60 by the Pacific West Area, a civilian federal agency, on August 16, 2023, with an ultimate completion date of November 14, 2023. The contract covers the procurement of a Sony MA900 cell sorter equipped with 488 nanometer, 638 nanometer, and 405 nanometer lasers. This award carries no set-aside designation and will be performed in Japan, the manufacturer's home...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on one (1) Sony LE-SA800 cell sorter. The contract has a ceiling value of $119,475.00 and a completion date of April 12, 2028. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Sony Biotechnology Inc., a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to support biomedical research for federal agencies. The contract, valued at $487,282.36, is for the provision of a cell sorter and spectral analyzer system. The contract does not have a set-aside designation, reflecting the specialized nature of the products...
- This is a $152,280.00 firm-fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health under the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on a single Sony MA900 cell sorter. The contract has a period of performance through June 30, 2029. Sony Biotechnology is a for-profit manufacturer that provides flow cytometry and imaging instrumentation, reagents, and services...
- The Department of Agriculture's Animal and Plant Health Inspection Service has awarded a $701,098.40 Firm Fixed Price contract to Sony Biotechnology Inc., a for-profit manufacturer, for the delivery of SONY MA900 MULTI APPLICATION BENCHTOP CELL SORTERS. This contract, which does not have a set-aside designation, runs through March 31, 2023. Sony Biotechnology Inc. is a provider of flow cytometry and imaging instrumentation, reagents, and services, and has previously held contracts with...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences has awarded a firm-fixed-price purchase order to Sony Biotechnology Inc., a for-profit manufacturer, to provide a maintenance/service agreement for the Sony SH800 cell sorter. The contract has a potential value of $105,280.00 and a completion date of May 31, 2028. The contract does not have a set-aside designation. Through this award, Sony Biotechnology will ensure...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Sony Biotechnology Inc., a for-profit manufacturer, for the delivery of a Sony MA900 multi-parameter cell sorter. The cell sorter will support future DCGT projects and collaborations within FDA to identity and characterize gene and cell therapy products. The potential value of the award is $224,880.80. This is an open competition solicitation and does not include any...
Sony Biotechnology Inc., operating as Sony Corp of America, was awarded a firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) Pittsburgh on January 18, 2024, for Sony cell sorter service. The contract has a ceiling value of $123,457.50 with an ultimate completion date of January 20, 2029, and no set-aside designation was utilized. The place of performance is Atlanta, Georgia. As a specialized manufacturer of advanced flow cytometry and cell sorting instrumentation based in San Jose, California, Sony Biotechnology Inc. provides maintenance and support services for sophisticated scientific equipment used in biomedical research. This award supports the CDC's research operations through maintenance and service of Sony cell sorter technology, consistent with the company's extensive history of providing scientific instrumentation support to federal health agencies. Sony Biotechnology Inc. has established itself as a primary provider of cell sorting and spectral flow cytometry equipment to the Department of Health and Human Services, including the National Institutes of Health and its various institutes. The contract aligns with the CDC's mission to support critical research infrastructure and represents a continuation of the agency's reliance on specialized scientific equipment providers to maintain operational capabilities for disease research and public health initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $24.7k | 12/16/25 | |
| P00001 | Exercise an Option | $24.7k | 12/6/24 | |
| Not listed | Not listed | $24.7k | 1/18/24 |